Hypoparathyroidism 2025 Summit:

Translating Science from the Laboratory to the Clinic

Friday, July 11, 2025 | 08:00-1600 PT
Yerba Buena salon 2-6; San Francisco Mariott Marquis
780 Mission St.
San Francisco, CA
ENDO2025 Pre-meeting

Register Now
Agenda

In-person,
full day workshop

ENDO2025
Pre-meeting

Friday, July 11,
2025 in San Francisco

Groundbreaking scientific discoveries in medicine are advancing bench to bedside research in hypoparathyroidism. This exciting summit features academic and industry scientists discussing these basic science breakthroughs and the latest developments of new therapies for hypoparathyroidism.

Learning Objectives

  • Identify unmet needs in the diagnosis and medical management of hypoparathyroidism
  • Outline recent insights in Calcium-Sensor Receptor (CaSR) activation and the potential of calcilytics
  • Discuss advances in PTH basic research and corresponding clinical implications
  • Describe advances in cell therapies research and corresponding clinical implications

Faculty

Maria Luisa Brandi

Summit Co-Chair
(University of Florence)

Aliya A. Khan

Summit Co-chair
(McMaster University)

Featured speakers include:

Wenhan Chang

PhD

University of California
San Francisco, United States

Bart Clarke

MD

Mayo Clinic College of Medicine
Rochester, United States

Michael Collins

MD

National Institutes of Health
Bethesda, United States

Arthur D. Conigrave

MD, PhD, FRACP, FRCP, FRSN

The University of Sydney
Sydney, Australia

Richard Di Marchi

PhD

Indiana University
Bloomington, United States

Ghada El-Hajj Fuleihan

American University of Beirut
Beirut, Lebanon

Thomas J. Gardella

PhD

Massachusetts General Hospital, Harvard Medical School
Boston, United States

Caroline M. Gorvin
Sir Henry Dale Fellow

University of Birmingham
Birmingham, United Kingdom

Steven Ing

MD

Ohio State University Medical Center
Columbus, United States

Patty Keating

HypoPARAthyroidism Association
Frisco, United States

Diane Krause

MD, PhD

Yale University
New Haven, United States

Michael A. Levine

MD, ML, MACE

University of Pennsylvania Perelman School of Medicine
Philadelphia, United States

Noriko Makita

MD

University of Tokyo
Tokyo, Japan

Michael Mannstadt

MD

Massachusetts General Hospital, Harvard Medical School
Boston, United States

Edward F. Nemeth

PhD

MetisMedica
Toronto, Canada 

Kelly Roszko

MD, PhD

National Institutes of Health
Bethesda, United States

Jad Sfeir

MD, MS

Mayo Clinic College of Medicine
Rochester, United States

Mishaela R. Rubin

Columbia University
New York, United States

Heide Siggelkow

MD, PhD

Göttingen Center for Endocrinology, Osteology, Rheumatology, Nuklear Medicine and Human Genetics
Göttingen, Germany

Dolores Shoback

MD

University of California San Francisco
San Francisco, United States

Kennett Sprogøe

EVP, Research and Product Development
Ascendis
Copenhagen, Denmark

Karen Winer

MD

National Institutes of Health
Bethesda, United States

Hao Zuo

PhD

Columbia University
New York, United States

Conflict of Interest Disclosures

Sponsors

The Summit has been planned independently by CSEM to achieve scientific integrity, objectivity, and balance. Unrestricted educational grants in the form of sponsorship have been received by:

Gold

Silver

Accreditation

The 2nd Parathyroid Summit will be an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification (MOC) Program of the Royal College of Physicians and Surgeons of Canada, as approved by The Canadian Society of Endocrinology and Metabolism.

Through an agreement between the Royal College of Physicians and Surgeons of Canada and the American Medical Association, physicians may convert Royal College MOC credits to AMA PRA Category 1 Credits™.

Live educational activities recognized by the Royal College of Physicians and Surgeons of Canada as Accredited Group Learning Activities (Section 1) are deemed by the European Union of Medical Specialists (UEMS) eligible for ECMEC®.

Through an agreement between the Royal College of Physicians and Surgeons of Canada and the Qatar Council for Healthcare Practitioners, healthcare practitioners participating in the QCHP CME/CPD program may record MOC Section 1 as QCHP Category 1 credits.

Evaluation

Please complete the evaluation to download your participation certificate.

Evaluate

Registration

$175 USD fee, includes breakfast & lunch
Registration for the ENDO2025 meeting is required

ENDO Registration

Select Sessions and Events